Li H - Search Results

1

Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.

Zhao Q, Wang Z, Huang W, Wang Q, Yu S, Zhou T, Han D, Wu Z, Gong H, Sun H, Zhang J, Wei Y, Li H, Zhang Z, Lin H, Li B. Zhao Q, et al. Among authors: li h, li b. Oncotarget. 2016 Feb 16;7(7):8422-31. doi: 10.18632/oncotarget.6871. Oncotarget. 2016. PMID: 26761213 Free PMC article. Clinical Trial.

2

Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis.

Zhang J, Yang F, Li B, Li H, Liu J, Huang W, Wang D, Yi Y, Wang J. Zhang J, et al. Among authors: li h, li b. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e305-16. doi: 10.1016/j.ijrobp.2011.04.034. Epub 2011 Jun 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21658853 Review.

3

A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.

Ding X, Li H, Wang Z, Huang W, Li B, Zang R, Sun H, Yi Y. Ding X, et al. Among authors: li h, li b. Technol Cancer Res Treat. 2013 Jun;12(3):251-7. doi: 10.7785/tcrt.2012.500310. Epub 2012 Dec 26. Technol Cancer Res Treat. 2013. PMID: 23289475 Free article.

4

Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study.

Wang D, Yang J, Zhu J, Li B, Zhai L, Sun M, Gong H, Zhou T, Wei Y, Huang W, Wang Z, Li H, Zhang Z. Wang D, et al. Among authors: li h, li b. Radiat Oncol. 2013 May 2;8:108. doi: 10.1186/1748-717X-8-108. Radiat Oncol. 2013. PMID: 23638721 Free PMC article. Clinical Trial.

5

Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy.

Zhang Z, Xu J, Zhou T, Yi Y, Li H, Sun H, Huang W, Wang D, Li B, Ying G. Zhang Z, et al. Among authors: li h, li b. Radiat Oncol. 2014 Feb 15;9:54. doi: 10.1186/1748-717X-9-54. Radiat Oncol. 2014. PMID: 24528546 Free PMC article.

6

The early predictive value of a decrease of metabolic tumor volume in repeated (18)F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy.

Huang W, Liu B, Fan M, Zhou T, Fu Z, Zhang Z, Li H, Li B. Huang W, et al. Among authors: li h, li b. Eur J Radiol. 2015 Mar;84(3):482-488. doi: 10.1016/j.ejrad.2014.11.020. Epub 2014 Dec 3. Eur J Radiol. 2015. PMID: 25533718

7

Prospective study of special stage II (T2b-3N0M0) non-small-cell lung cancer treated with hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy.

Zhang W, Liu C, Lin H, Song Y, Huang W, Li H, Li M, Li B. Zhang W, et al. Among authors: li h, li m, li b. J Cancer Res Ther. 2015 Apr-Jun;11(2):381-7. doi: 10.4103/0973-1482.157332. J Cancer Res Ther. 2015. PMID: 26148604 Free article.

8

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up.

Liu M, Wang Z, Zhou T, Zhou A, Zhao Q, Li H, Sun H, Huang W, Li B. Liu M, et al. Among authors: li h, li b. Oncotarget. 2017 Mar 16;8(31):51848-51858. doi: 10.18632/oncotarget.16288. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881694 Free PMC article.

9

High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer.

Zhao Q, Liu M, Wang Z, Huang W, Allen Li X, Zhou T, Zhang J, Zhang Z, Wang Q, Yu S, Han D, Sun H, Li H, Lin H, Li B. Zhao Q, et al. Among authors: li h, li b. Radiother Oncol. 2020 Apr;145:7-12. doi: 10.1016/j.radonc.2019.11.024. Epub 2019 Dec 21. Radiother Oncol. 2020. PMID: 31869678

10

Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.

Li BS, Zhou T, Wang ZT, Li HS, Sun HF, Zhang ZC, Lin HQ, Wei YM, Gong HY, Huang W, Yi Y, Wang LY. Li BS, et al. Radiother Oncol. 2009 Dec;93(3):458-61. doi: 10.1016/j.radonc.2009.08.002. Epub 2009 Sep 3. Radiother Oncol. 2009. PMID: 19733411 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114,014 results

Search Page